Victory Capital Management
TMBR

Victory Capital Management’s Timber Pharmaceuticals, Inc. TMBR Stock Holding History

Victory Capital Management’s Portfolio TMBR Stock Details TMBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-292
Closed -$2K – 2768
2022
Q3 		$2K Buy
+292
New +$2.45K ﹤0.01% 2693
2020
Q2 		– Sell
-8
Closed -$2K – 3539
2020
Q1 		$2K Buy
+8
New +$2.04K ﹤0.01% 3707
2019
Q4 		– Sell
-3
Closed -$1K – 3522
2019
Q3 		$1K Buy
+3
New +$719 ﹤0.01% 3741

Other funds holding TMBR

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
CPG
Cornerstone Planning Group Fairfield, New Jersey $749M AUM 17.97% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Victory Capital Management's TMBR Position: Q4 2022 in Review

Victory Capital Management sold out of Timber Pharmaceuticals, Inc. (TMBR) in Q4 2022, closing a stake of 292 shares — an estimated $2K sold.

Victory Capital Management first reported a position in TMBR in Q3 2019 and held it in 3 quarters. The position peaked at $2K in Q3 2022. 11 funds tracked by Wall St. Rank hold TMBR as of Q4 2022.

  • Victory Capital Management reported no remaining Timber Pharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
  • Victory Capital Management sold 292 Timber Pharmaceuticals, Inc. shares in Q4 2022, an estimated $2K.
  • Victory Capital Management first reported a position in Timber Pharmaceuticals, Inc. in Q3 2019 and held it in 3 quarters.
  • Victory Capital Management's Timber Pharmaceuticals, Inc. position peaked at $2K in Q3 2022.
  • 11 funds tracked by Wall St. Rank held Timber Pharmaceuticals, Inc. as of Q4 2022.

Based on Victory Capital Management's 13F filing for Q4 2022, filed 9 Feb 2023.